Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Accumulated Expenses: 2021-2022

  • Cullinan Therapeutics' Other Accumulated Expenses rose 100.92% to $2.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year increase of 100.92%. This contributed to the annual value of $2.0 million for FY2022, which is 100.92% up from last year.
  • As of Q4 2022, Cullinan Therapeutics' Other Accumulated Expenses stood at $2.0 million, which was up 100.92% from $973,000 recorded in Q4 2021.
  • Cullinan Therapeutics' Other Accumulated Expenses' 5-year high stood at $2.0 million during Q4 2022, with a 5-year trough of $973,000 in Q4 2021.
  • Its 2-year average for Other Accumulated Expenses is $1.5 million, with a median of $1.5 million in 2021.
  • Data for Cullinan Therapeutics' Other Accumulated Expenses shows a peak YoY skyrocketed of 100.92% (in 2022) over the last 5 years.
  • Cullinan Therapeutics' Other Accumulated Expenses (Quarterly) stood at $973,000 in 2021, then spiked by 100.92% to $2.0 million in 2022.